Blepharoptosis
31
3
3
16
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.5%
2 terminated out of 31 trials
88.9%
+2.3% vs benchmark
19%
6 trials in Phase 3/4
38%
6 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 16 completed trials
Clinical Trials (31)
Effect of Suture Material on Eyelid Height Stability After Anterior White-Line Advancement for Aponeurotic Ptosis.
A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis
Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study
Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery
A Study in Chinese Patients With Acquired Blepharoptosis
Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis
Clinical Trial to Improve the Magnetic Levator Prosthesis
A Pharmacokinetics (PK) Study in Healthy Adults
Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis
Red Light Ptosis Proof-of-Concept
Blepharoptosis in Indonesia: A 5-Year Multicenter Study on Characteristics and Surgical Evaluation
NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy
Subconjunctival Injection of Local Anesthetic in Anterior Blepharoptosis Repair
Fibrin Sealant in Eyelid Surgery
Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis
Custom Print Megnetic Levator Prosthesis Pilot Comparison
Magnetic Correction of Eye Lid Paralysis
Study of Safety of RVL-1201 in Treatment of Blepharoptosis
Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis
Management of Severe Congenital Blepharoptosis